The reasons for plastic surgery are diverse and varied, and often go against expectations Plastic surgery procedures are still sometimes stigmatized in our society, as some judgmental onlookers have wrongly tended to dismiss such operations as ...
Read MoreResearch presented at the 29 th Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human papillomavirus, including the two that cause 70 percent of all cervical ...
Read MoreMark Riccio, director of Cornell University's multi-scale 3D computed tomography (CT) imaging facility, is using the online crowd-funding platform Kickstarter to bring non-invasive 3D, 4D and even 5D imaging to researchers and would-be superheros ...
Read More- MediaLINC unlocks the real value of Hospital TVs Today Lincor announced general availability of MediaLINC - its innovative Android-based Patient Engagement solution that delivers a range of education, entertainment and clinical content direct ...
Read MoreWhy do many weight-loss programs fail? Why are there so many contradicting weight-loss approaches presented in the media? From dietary nutritionists to fitness gurus, many have offered their insights and ideas of the best weight-loss program to ...
Read MoreMylan Inc. (Nasdaq: MYL) today announced that it has launched Potassium Chloride Extended-release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg), which is the generic version of Upsher-Smith's Klor-Con®. Mylan received final approval from the ...
Read MoreTaking a Peek Behind Closed Doors! ColdChainIQ.com , a division of IQPC, is delighted to announce their brand new Benchmarking Report - a collection of some of the best case studies of leading pharmaceutical and biotech companies in the world. ...
Read MoreMenzies Aviation Bobba, operating a cargo terminal at Kempegowda International Airport, Bengaluru, has opened an exclusive Pharma Cold Zone on 20th August for the handling of pharma products. (Photo: ...
Read MoreBioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX ® (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX ® in the EU, today ...
Read MoreAptuit LLC announces that Aptuit SSCI, located in West Lafayette, Indiana , has enhanced its capabilities in the areas of structure determination and characterization of small and large molecules, including biologic drugs, metabolites, and ...
Read MoreENSPIRIT Trial to Continue as Planned Following Completion of the First of Two Interim Futility Analyses OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of ...
Read More"Stop the Thyroid Madness II: How Thyroid Experts are Challenging Ineffective Treatments and Improving the Lives of Patients" Stop the Thyroid Madness LLC (STTM) and author/editor Janie A. Bowthorpe , M.Ed, announce the release of the most ...
Read MoreTwice-Weekly Prophylactic Regimen Resulted in 95% Reduction in Median Annualized Bleed Rate Compared to On-Demand Nektar Therapeutics (NASDAQ: NKTR) reports Baxter International Inc. today announced positive results from its Phase 3 pivotal ...
Read MoreBruckner Oncology has initiated an FDA approved Phase II-III clinical trial which adds Vitamin C to chemotherapy "core" regimens (GFLIO and GFLIO-D) for patients with locally advanced and metastatic pancreatic cancer (APC). Vitamin C was selected ...
Read MoreSubscribe to our Free Newsletters!